A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Recruiting

Phase 2

GLIADEL vs. Stereotactic RadiosurgeryA Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Sponsor:

University of Nebraska

Code:

NCT04222062

Conditions

Brain Tumor - Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carmustine 7.7Mg Wafer

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Nebraska on 2025-02-27.